Janssen Biotech, Inc.

Janssen Biotech, Inc.
Share
For more than 30 years, Janssen Biotech, Inc., a member of Janssen Pharmaceutical Companies of Johnson & Johnson, has delivered on the promise of new treatments and ways to improve the health of individuals with serious disease. Built upon a rich legacy of firsts, Janssen Biotech pursues innovative solutions in immunology, oncology, urology and nephrology.

Janssen Biotech, Inc.

 •  January 12

It’s a real paradox: As of March 2014, there were more than 31,850 biomarkers listed in the GOBIOM database (GVK BIO Online Biomarker Database), but only 32 valid genomic biomarkers were included in United States Food and Drug Administration (FDA) approved drug labels. And none of these was a multiplex in vitro diagnostic assay based on proteomic...

Janssen Biotech, Inc.

 •  November 9, 2016

Pre-clinical data published in Nature shows approach reduced hard-to-reach reservoirs of HIV-like virus LEIDEN, NETHERLANDS, Nov. 9, 2016 – Janssen Vaccines & Prevention B.V., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, today announced results of a new study published in Nature which points to a potential new approach against...

Janssen Biotech, Inc.

 •  October 18, 2016

NEW BRUNSWICK, N.J., Oct. 18, 2016 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced sales of $17.8 billion for the third quarter of 2016, an increase of 4.2% as compared to the third quarter of 2015. Operational sales results increased 4.3% and the negative impact of currency was 0.1%. Domestic sales increased 6.7%. International sales...

Janssen Biotech, Inc.

 •  July 15, 2016

Castilho in the lab With mosquito season in full swing, concerns over the Zika virus continue to climb—making one Brazilian scientist’s cutting-edge work particularly timely. Leda Castilho, Ph.D., a professor at the Federal University of Rio De Janeiro’s Alberto Luiz Coimbra Institute of Graduate Studies and Engineering Research, was named the...

Janssen Biotech, Inc.

 •  December 5, 2014

Diabetics are forced to become used to finger pricks they endure sometimes up to several times a day. Jones Innovative Medical Solutions is working to take the pain out of glucose testing. This startup out of Little Rock Arkansas has developed a product called the Bifurcated Venous Access Device (BVAD). The BVAD is a medical device that provides...